fda warning letter bpc 157 unapproved new drug Partnership for Safe Medicines urges advisory committee to reject compounding of peptides – Partnership for Safe Medicines FDA scientists flag concerns with
Description
Extreme acid or alkaline conditions massively accelerate hydrolysis and should never be used for storage
Hematocrit and reticulocyte counts should be repeated daily from the 5th to 7th days of therapy and then frequently until the hematocrit is normal
Not medical or dosing advice
Do check with your doctor if your dosage of Vitamin B12 is sufficient
The agency said the company failed to meet CGMP requirements, including implementing and adhering to its risk-based corrective and preventive action (CAPA) procedures
Treating vitamin B 12 deficiency Treatment for this condition involves replacing the missing vitamin B 12
